Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Costs, Cognitive Abilities and Quality of Life After Transcatheter Aortic Valve Implantation and Surgical Aortic Valve Replacement (CCQ)

11 de novembro de 2016 atualizado por: Francesco Saia, MD, PhD, IRCCS Azienda Ospedaliero-Universitaria di Bologna

Multicenter, prospective, observational study in aortic stenosis (AS) patients undergoing transcatheter aortic valve implantation (TAVI) or high-risk patients undergoing aortic valve replacement (AVR).

The objectives of the study are:

  1. Description of neurocognitive status before and after transcatheter aortic valve implantation and aortic valve replacement procedures
  2. Description of Quality of Life (QoL) after these procedures
  3. Defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities
  4. Assessment of costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and costs of follow-up.

Visão geral do estudo

Descrição detalhada

In Italy, a nation-wide observational study endorsed by the Superior Institute of Health has been previously launched in order to evaluate appropriateness and effectiveness of aortic valve replacement (AVR) and transcatheter aortic valve implantation (TAVI) procedures: the OBservational Study of Effectiveness of AVR-TAVI procedures for severe Aortic steNosis Treatment (OBSERVANT). The present study was designed to complement the national survey on TAVI and AVR procedures including data about costs, cognitive functions and quality of life after these procedures. This integrated framework may help defining the relevance of baseline psychological, emotional and cognitive factors on the outcomes associated to the different treatment modalities and, on the other hand, should enable accurate evaluation of the impact of each kind of treatment on quality of life and neuropsychological functions. These elements could also represent relevant keys to decision-making to the different therapeutic strategies. In addition, we aim to ascertain costs associated to each of the above mentioned strategies of treatment, including costs of the index hospitalization and follow-up costs. Costs estimate, combined to the integrated physical and mental health status outcome for each treatment modality, may represent the background for subsequent cost-effectiveness analyses.

All consecutive patients undergoing transcatheter aortic valve implantation or aortic valve replacement (if age ≥ 80 years or Logistic Euroscore ≥ 15%) for aortic stenosis at participating centers during the period of enrollment will be included in the registry, after release of written informed consent. Allocation of patients to different treatment groups will be performed jointly by a cardiologist and a cardiac surgeon on the basis of a complete clinical framework, independently from the present study and in accordance with available guidelines. Type of treatment (for example, access site for TAVI, type of prosthesis…) will be decided by the physicians based on local clinical practice and general principles of good clinical practice.

The administration of neurocognitive and quality of life questionnaires will be performed before the procedure and after 3 months and 1 year by trained personnel following standard operation procedures defined by a coordinating unit. A telephone and web-based support for operators will be available throughout the entire duration of the study. A common methodology for data collection and analysis is defined to guarantee data reliability and homogeneity of assessments among the participating units. The cost analysis will be coordinated by the Regional Healthcare and Social Agency of the Emilia Romagna Region.

Data will be collected in a web-based database (OBSERVANT) through dedicated Case Records Forms and a final database will be built by merging this database with a separate database for costs and Hospital Discharge Records and Mortality Registry databases.

Tipo de estudo

Observacional

Inscrição (Real)

518

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

      • Bologna, Itália, 40138
        • Institute of Cardiology, Azienda Ospedaliero-Universitaria di Bologna

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

All consecutive patients undergoing TAVI or AVR for AS at participating centers during the period of enrollment

Descrição

Inclusion Criteria:

  • All consecutive patients undergoing TAVI at participating centers during the period of enrollment
  • All consecutive patients aged ≥80 years or with Logistic Euroscore ≥15% undergoing AVR at participating centers during the period of enrollment

Exclusion Criteria:

  • Absence of informed consent

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: Coorte
  • Perspectivas de Tempo: Prospectivo

Coortes e Intervenções

Grupo / Coorte
Intervenção / Tratamento
Transcatheter aortic valve implantation
All consecutive patients undergoing TAVI at participating centres during study period
Patients undergoing TAVI with transfemoral, transapical, or any other vascular access
Outros nomes:
  • Edwards Sapien XT
  • Corevalve
  • Acurate-TA
Aortic Valve Replacement
All consecutive patients aged ≥ 80 years or with Logistic Euroscore≥ 15% undergoing AVR for AS at participating centers during the period of enrollment
Surgical AVR, with all kind of commercially available prosthesis (stented, stentless, mechanical)

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Mini Mental State Examination (MMSE)
Prazo: baseline, 3-month, 12-month
Changes in cognitive function after transcatheter aortic valve implantation and surgical aortic valve replacement
baseline, 3-month, 12-month
Hospital Anxiety and Depression Scale (HADS)
Prazo: baseline, 3-month, 12-month
Changes of emotional status after transcatheter aortic valve implantation and surgical aortic valve replacement
baseline, 3-month, 12-month
Minnesota Living with Heart Failure Questionnaire (MLHFQ)
Prazo: baseline, 3-month, 12-month
Changes in quality of life after transcatheter aortic valve implantation and surgical aortic valve replacement
baseline, 3-month, 12-month
In-hospital costs
Prazo: Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement
Calculation of precise hospital costs for transcatheter aortic valve implantation and surgical Aortic Valve Replacement, including costs of hospitalization, drugs and devices.
Participants will be followed for the duration of hospital stay, an expected average of 10 days for transcatheter aortic valve implantation and 2 weeks for surgical Aortic Valve Replacement

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Myocardial infarction
Prazo: 30-day, 12-month and up to 2-year (longest available follow-up)
Incidence of myocardial infarction
30-day, 12-month and up to 2-year (longest available follow-up)
Stroke
Prazo: 30-day, 12-month and up to 2-year (longest available follow-up)
Incidence of stroke
30-day, 12-month and up to 2-year (longest available follow-up)
Pace-maker implantation
Prazo: 30-day, 12-month
Need for permanent pacing
30-day, 12-month
Vascular complications
Prazo: 30-day
Incidence of vascular complications as defined by the VARC
30-day
Bleedings
Prazo: 30-day
Incidence of bleedings as defined by the VARC
30-day
Acute kidney injury
Prazo: 30-day
Incidence of AKI as defined by the VARC
30-day
Follow-up costs
Prazo: 12-month
Evaluation of costs during follow-up, including new hospital admissions, outpatient clinic and drugs
12-month

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de dezembro de 2011

Conclusão Primária (Real)

1 de janeiro de 2016

Conclusão do estudo (Real)

1 de janeiro de 2016

Datas de inscrição no estudo

Enviado pela primeira vez

8 de maio de 2013

Enviado pela primeira vez que atendeu aos critérios de CQ

9 de maio de 2013

Primeira postagem (Estimativa)

13 de maio de 2013

Atualizações de registro de estudo

Última Atualização Postada (Estimativa)

15 de novembro de 2016

Última atualização enviada que atendeu aos critérios de controle de qualidade

11 de novembro de 2016

Última verificação

1 de novembro de 2016

Mais Informações

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

3
Se inscrever